Hematopoietic stem cell mobilization for allogeneic stem cell transplantation by motixafortide, a novel CXCR4 inhibitor.

Autor: Crees ZD; Division of Oncology, Washington University School of Medicine, St. Louis, MO., Rettig MP; Division of Oncology, Washington University School of Medicine, St. Louis, MO., Bashey A; Blood and Marrow Transplant Program, Northside Hospital, Atlanta, GA., Devine SM; Center for International Blood and Marrow Transplant Research, National Marrow Donor Program, Minneapolis, MN., Jaglowski S; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, OH., Wan F; Division of Oncology, Washington University School of Medicine, St. Louis, MO., Zhou A; Division of Oncology, Washington University School of Medicine, St. Louis, MO., Harding M; Division of Oncology, Washington University School of Medicine, St. Louis, MO., Vainstein-Haras A; BioLineRx Ltd, Modi'in, Israel., Sorani E; BioLineRx Ltd, Modi'in, Israel., Gliko-Kabir I; BioLineRx Ltd, Modi'in, Israel., Grossman BJ; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO., Westervelt P; Division of Oncology, Washington University School of Medicine, St. Louis, MO., DiPersio JF; Division of Oncology, Washington University School of Medicine, St. Louis, MO., Uy GL; Division of Oncology, Washington University School of Medicine, St. Louis, MO.
Jazyk: angličtina
Zdroj: Blood advances [Blood Adv] 2023 Sep 26; Vol. 7 (18), pp. 5210-5214.
DOI: 10.1182/bloodadvances.2023010407
Databáze: MEDLINE